Clinical trial
ACURATE Enhance Post Market Study
NCT06959862 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ACURATE Enhance Post Market Study
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- May 31, 2025
- Completion date
- April 30, 2027
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
aortic diseases, aortic valve calcification, aortic valve stenosis